Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD).

Source:http://linkedlifedata.com/resource/pubmed/id/11727737

Hum. Gene Ther. 2001 Nov 1 12 16 2029-32

Download in:

View as

Triples

General Info

PMID
11727737